Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration.
Menu
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration.
We acknowledge the Traditional Owners and Custodians of the land, the Eora Nation, on which we work and pay our respects to their Elders, both past and present.
Everyone deserves the best care. We foster an inclusive culture by embracing and valuing diversity and equality for our work colleagues and patients. This philosophy extends to everyone we interact with and the communities we serve. You are valued, regardless of race, colour, sexual orientation, gender identity, religion, national origin, ancestry, physical abilities and age.
